This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Japanese Healthy Adult Males
and you are
between 20 and 35
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the bioequivalence of a single oral dose of 2 different drug forms of TAK-536 pediatric formulation and a single oral dose of TAK-536 commercial tablet in healthy Japanese adult male participants.

Provided treatments

  • Drug: TAK-536 Tablet
  • Drug: TAK-536 Dry Syrup Formulation
  • Drug: TAK-536 Ganule Formulation
Tris trial is registered with FDA with number: NCT02401464. The sponsor of the trial is Takeda and it is looking for 52 volunteers for the current phase.
Official trial title:
A Randomized, Open-label, 2×2 Crossover, Phase I Study to Evaluate the Bioequivalence of Single Oral Dose of TAK-536 Pediatric Formulations and TAK-536 Commercial Tablet in Healthy Adult Male Subjects